The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125259351 12525935 1 I 20160623 20160705 20160705 EXP NL-BAUSCH-BL-2016-015631 BAUSCH AND LOMB AALST J, TEERNSTRA O, WEBER W, RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL. 2016;9:117-120. 63.00 YR F Y 0.00000 20160705 MD NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125259351 12525935 1 PS DIAZEPAM. DIAZEPAM 1 Oral Y 20648 5 MG TID
125259351 12525935 2 SS MORPHINE MORPHINE 1 Intrathecal 0 3.5 MG
125259351 12525935 3 SS MORPHINE MORPHINE 1 Intrathecal 0 .5 MG
125259351 12525935 4 SS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Unknown Y 0 300 MG QID
125259351 12525935 5 SS AMOXICILLIN/ CLAVULANIC ACID 500/125 MG AMOXICILLINCLAVULANIC ACID 1 Unknown Y 0 QID
125259351 12525935 6 SS AMOXICILLIN/ CLAVULANIC ACID 1000/200 MG AMOXICILLINCLAVULANIC ACID 1 Intravenous (not otherwise specified) Y 0 QID
125259351 12525935 7 SS CLONIDINE. CLONIDINE 1 Oral Y 0 .15 MG TID
125259351 12525935 8 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral Y 0 20 MG QID
125259351 12525935 9 SS DUROGESIC FENTANYL 1 Transdermal Y 0 100 UG
125259351 12525935 10 SS AMITRIPTYLINE AMITRIPTYLINE 1 Unknown 0 25 MG QD
125259351 12525935 11 SS AMITRIPTYLINE AMITRIPTYLINE 1 Unknown 0 10 MG
125259351 12525935 12 C SEVOFLURANE. SEVOFLURANE 1 0
125259351 12525935 13 C PROPOFOL. PROPOFOL 1 0
125259351 12525935 14 C SUFENTANIL SUFENTANIL 1 0
125259351 12525935 15 C ROCURONIUM ROCURONIUM BROMIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125259351 12525935 1 Muscle spasms
125259351 12525935 2 Amputation stump pain
125259351 12525935 4 Product used for unknown indication
125259351 12525935 5 Product used for unknown indication
125259351 12525935 6 Product used for unknown indication
125259351 12525935 7 Pain
125259351 12525935 8 Pain
125259351 12525935 9 Pain
125259351 12525935 10 Amputation stump pain
125259351 12525935 12 General anaesthesia
125259351 12525935 13 General anaesthesia
125259351 12525935 14 General anaesthesia
125259351 12525935 15 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
125259351 12525935 OT
125259351 12525935 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125259351 12525935 Amputation stump pain
125259351 12525935 Blindness cortical
125259351 12525935 Body temperature increased
125259351 12525935 Condition aggravated
125259351 12525935 Drug withdrawal syndrome
125259351 12525935 Hemiparesis
125259351 12525935 Implant site extravasation
125259351 12525935 Implant site infection
125259351 12525935 Muscle spasms
125259351 12525935 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found